Background: PRKCDBP is a tumor suppressor whose epigenetic inactivation contributes to the malignant progression of gastric and other tumors, in part, through attenuated p53 response to stresses.
Description: Rabbit polyclonal to PRKCDBP
Immunogen: KLH conjugated synthetic peptide derived from PRKCDBP
Specificity: ·Reacts with Human, Mouse and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/200-500. Predicted Mol wt: 28 kDa;
·Immunohistochemistry (Paraffin/frozen tissue section): 1/100-500;
·Immunocytochemistry: 1/100-500;
·ELISA: 1/1000;
·Optimal working dilutions must be determined by the end user.
